Design, synthesis, and structure–activity relationships of indole-3-heterocycles as agonists of the CB1 receptor
✍ Scribed by Angus J. Morrison; Julia M. Adam; James A. Baker; Robert A. Campbell; John K. Clark; Jean E. Cottney; Maureen Deehan; Anna-Marie Easson; Ruth Fields; Stuart Francis; Fiona Jeremiah; Neil Keddie; Takao Kiyoi; Duncan R. McArthur; Karsten Meyer; Paul D. Ratcliffe; Jurgen Schulz; Grant Wishart; Kazuya Yoshiizumi
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 401 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
Novel indole-3-heterocycles were designed and synthesized and found to be potent CB1 receptor agonists. Starting from a microsomally unstable lead 1, a bioisostere approach replacing a piperazine amide was undertaken. This was found to be a good strategy for improving stability both in vitro and in vivo. This led to the discovery of 24, which had an increased duration of action in the mouse tail flick test in comparison to the lead 1.
📜 SIMILAR VOLUMES
## Abstract The discovery, synthesis, and SAR of a novel series of cannabinoid 1 (CB~1~) and cannabinoid 2 (CB~2~) receptor ligands are reported.